ZA813479B - Process for the isolation of viral glycoproteic antigens and its application to the preparation of vaccines - Google Patents
Process for the isolation of viral glycoproteic antigens and its application to the preparation of vaccinesInfo
- Publication number
- ZA813479B ZA813479B ZA00813479A ZA813479A ZA813479B ZA 813479 B ZA813479 B ZA 813479B ZA 00813479 A ZA00813479 A ZA 00813479A ZA 813479 A ZA813479 A ZA 813479A ZA 813479 B ZA813479 B ZA 813479B
- Authority
- ZA
- South Africa
- Prior art keywords
- vaccines
- viral
- isolation
- preparation
- application
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 238000002955 isolation Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
- 230000003612 virological effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8012522A FR2483779A1 (fr) | 1980-06-05 | 1980-06-05 | Procede pour isoler des antigenes glycoproteiques viraux et son application a la preparation de vaccins |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA813479B true ZA813479B (en) | 1982-06-30 |
Family
ID=9242745
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA00813479A ZA813479B (en) | 1980-06-05 | 1981-05-25 | Process for the isolation of viral glycoproteic antigens and its application to the preparation of vaccines |
Country Status (19)
Country | Link |
---|---|
US (1) | US4344935A (xx) |
EP (1) | EP0041880B1 (xx) |
JP (1) | JPS5726624A (xx) |
AR (1) | AR228865A1 (xx) |
AT (1) | ATE3239T1 (xx) |
AU (1) | AU546088B2 (xx) |
CA (1) | CA1174598A (xx) |
DE (1) | DE3160264D1 (xx) |
DK (1) | DK228081A (xx) |
ES (1) | ES8203225A1 (xx) |
FI (1) | FI811685L (xx) |
FR (1) | FR2483779A1 (xx) |
GR (1) | GR74610B (xx) |
IE (1) | IE51226B1 (xx) |
IL (1) | IL62913A (xx) |
NO (1) | NO811873L (xx) |
NZ (1) | NZ197306A (xx) |
PT (1) | PT73032B (xx) |
ZA (1) | ZA813479B (xx) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4721675A (en) * | 1982-02-01 | 1988-01-26 | Abbott Laboratories | Production of hepatitis A virus in vitro utilizing a persistently virus infected cell culture system |
US4645666A (en) * | 1982-06-08 | 1987-02-24 | The Regents Of The University Of California | Vaccine for bluetongue disease employing platinum compounds |
GB8502096D0 (en) * | 1985-01-28 | 1985-02-27 | Medical Res Council | Influenza vaccine |
NZ224422A (en) | 1987-05-05 | 1990-11-27 | Molecular Eng Ass | Composition adapted for intranasal immunisation against viral infection comprising a glycoprotein complexed with a lipid |
US4909940A (en) * | 1987-12-30 | 1990-03-20 | New York Blood Center, Inc. | Extraction of process chemicals from labile biological mixtures with organic alcohols or with halogenated hydrocarbons |
US4975119A (en) * | 1989-04-25 | 1990-12-04 | Rheox, Inc. | Liquid antisettling agents for organic coating compositions |
US5741493A (en) * | 1991-01-24 | 1998-04-21 | Pasteur Merieux Serums Et Vaccins | Vaccine composition against influenza, with synergic effects, containing influenza virus core as an additive |
FR2671974A1 (fr) * | 1991-01-24 | 1992-07-31 | Pasteur Merieux Serums Vacc | Composition vaccinale contre la grippe, a effet synergique, contenant comme additif du core de virus grippal. |
US6780630B1 (en) * | 1992-07-10 | 2004-08-24 | Baylor College Of Medicine | Parenteral immunization against rotavirus |
FR2723740B1 (fr) * | 1994-08-16 | 1996-11-08 | Pasteur Merieux Serums Vacc | Procede de preparation d'antigenes du virus grippal, antigenes obtenus et leurs applications |
DE69629812T2 (de) | 1995-06-14 | 2004-04-01 | Baylor College Of Medicine, Houston | Impfstoff gegen rotavirus infektionen enthaltend peptide des viralenterotoxines nsp4 |
US6673355B1 (en) | 1995-06-14 | 2004-01-06 | Baylor College Of Medicine | Rotavirus enterotoxin NSP4 and methods of using same |
DE19938767C2 (de) * | 1999-08-16 | 2002-10-24 | Tad Pharma Gmbh | Spaltimpfstoffe |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE661402A (xx) | 1964-03-20 | |||
US3847737A (en) * | 1965-03-22 | 1974-11-12 | A Kanarek | Inactivation of myxoviruses and method of preparing a vaccine therefrom |
US3629470A (en) * | 1968-04-08 | 1971-12-21 | Burroughs Wellcome Co | Process for purification of animal rna viruses |
BR6915288D0 (pt) * | 1969-03-15 | 1973-02-08 | Bayer Ag | Processo para a purificacao de solucoes do virus da febre aftosa |
US3989818A (en) * | 1970-08-14 | 1976-11-02 | South African Inventions Development Corporation | Influenza virus vaccine |
US3790552A (en) * | 1972-03-16 | 1974-02-05 | Us Health | Method of removing hepatitis-associated antigen from a protein fraction using polyethylene glycol |
US3962421A (en) * | 1973-06-18 | 1976-06-08 | American Home Products Corporation | Method for the disruption of lipid-containing viruses |
GB1486557A (en) | 1973-10-18 | 1977-09-21 | Flockhart & Co | Process for the preparation of pyrogen-free sub-unit vaccine |
US3951937A (en) * | 1973-12-20 | 1976-04-20 | The Community Blood Council Of Greater New York, Inc. | Large scale purification of hepatitis type B antigen using polyethylene glycol |
US4140762A (en) * | 1974-01-14 | 1979-02-20 | Sandoz Ltd. | Influenza sub-unit vaccine |
US4064232A (en) * | 1974-01-14 | 1977-12-20 | Sandoz Ltd. | Process for isolating the immunogenic components of influenza viruses |
AU507149B2 (en) | 1975-01-16 | 1980-02-07 | Mount Sinai School Of Medicine Of The City University Of New York, The | Method of influenza immunization |
FR2422720A2 (fr) | 1977-04-26 | 1979-11-09 | Elf Aquitaine | Separation et purification de proteines par chromatographie |
FI66020C (fi) * | 1977-09-19 | 1984-08-10 | Merck & Co Inc | Foerfarande foer framstaellning av antigeniska immunogeniska subunits av hsv-1 och hsv-2 |
DE2750045A1 (de) * | 1977-11-09 | 1979-05-10 | Behringwerke Ag | Verfahren zur entfernung von detergentien aus virusantigensuspensionen |
-
1980
- 1980-06-05 FR FR8012522A patent/FR2483779A1/fr active Granted
-
1981
- 1981-05-11 AR AR285278A patent/AR228865A1/es active
- 1981-05-14 PT PT73032A patent/PT73032B/pt unknown
- 1981-05-19 US US06/265,084 patent/US4344935A/en not_active Expired - Fee Related
- 1981-05-20 IL IL62913A patent/IL62913A/xx unknown
- 1981-05-22 AT AT81400815T patent/ATE3239T1/de not_active IP Right Cessation
- 1981-05-22 EP EP81400815A patent/EP0041880B1/fr not_active Expired
- 1981-05-22 DE DE8181400815T patent/DE3160264D1/de not_active Expired
- 1981-05-25 ZA ZA00813479A patent/ZA813479B/xx unknown
- 1981-05-25 DK DK228081A patent/DK228081A/da not_active Application Discontinuation
- 1981-05-26 IE IE1168/81A patent/IE51226B1/en unknown
- 1981-05-27 ES ES502549A patent/ES8203225A1/es not_active Expired
- 1981-05-29 AU AU71170/81A patent/AU546088B2/en not_active Ceased
- 1981-06-01 FI FI811685A patent/FI811685L/fi not_active Application Discontinuation
- 1981-06-02 CA CA000378801A patent/CA1174598A/en not_active Expired
- 1981-06-02 GR GR65127A patent/GR74610B/el unknown
- 1981-06-03 NO NO811873A patent/NO811873L/no unknown
- 1981-06-04 JP JP8504581A patent/JPS5726624A/ja active Pending
- 1981-06-04 NZ NZ197306A patent/NZ197306A/en unknown
Also Published As
Publication number | Publication date |
---|---|
DE3160264D1 (en) | 1983-06-16 |
JPS5726624A (en) | 1982-02-12 |
PT73032B (fr) | 1982-07-01 |
AR228865A1 (es) | 1983-04-29 |
AU546088B2 (en) | 1985-08-15 |
IE51226B1 (en) | 1986-11-12 |
EP0041880A1 (fr) | 1981-12-16 |
ES502549A0 (es) | 1982-04-01 |
FR2483779A1 (fr) | 1981-12-11 |
DK228081A (da) | 1981-12-06 |
US4344935A (en) | 1982-08-17 |
FI811685L (fi) | 1981-12-06 |
IL62913A0 (en) | 1981-07-31 |
GR74610B (xx) | 1984-06-29 |
CA1174598A (en) | 1984-09-18 |
NO811873L (no) | 1981-12-07 |
FR2483779B1 (xx) | 1983-07-22 |
PT73032A (fr) | 1981-06-01 |
NZ197306A (en) | 1984-03-16 |
ES8203225A1 (es) | 1982-04-01 |
EP0041880B1 (fr) | 1983-05-11 |
ATE3239T1 (de) | 1983-05-15 |
IE811168L (en) | 1981-12-05 |
AU7117081A (en) | 1981-12-10 |
IL62913A (en) | 1984-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS55136116A (en) | Preparation of silicon | |
JPS52114018A (en) | Purification and isolation of hepatisis virus for producing vaccine | |
PT72743A (en) | Process for the preparation of diamino-pyridines useful aschemical intermediates and cardiotonics | |
DE2961796D1 (en) | Process for the preparation and separation of para-xylene | |
ZA813479B (en) | Process for the isolation of viral glycoproteic antigens and its application to the preparation of vaccines | |
GB2015156B (en) | Determination of antigens of antibodies | |
JPS56102786A (en) | Preparation of concentrated virus group | |
EP0003481A3 (en) | Highly filled sheets and method of preparation thereof | |
ZA802786B (en) | Process for the preparation and isolation of methyl-tert-butyl ether | |
NZ203190A (en) | Vaccines of infections bronchitis virus | |
GB2058063B (en) | Process for the preparation of 2-mercaptoalkyl-sulphides and 2-mercaptoalkylethers | |
PT72077A (en) | Infectious bronchitis vaccines for poultry and process forthe preparation of such vaccines | |
DE3064315D1 (en) | Process for the preparation of methyl polyethers and methyl polyethers prepared by this process | |
GB2044757B (en) | Preparation of amines | |
PT70556A (en) | Vaccines against diseases caused by reo-virus and process for the preparation of those vaccines | |
GB2073735B (en) | Preparation of tertiary amines | |
DE3067697D1 (en) | 1-azolyl-1-halogen-alkan-2-ones and process for the preparation of 1-azolyl-1-phenoxy-alkan-2-ones | |
DE3260740D1 (en) | Process for the preparation and isolation of n-alkyl oxiranes | |
JPS55149114A (en) | Preparation of silicon | |
IL59143A (en) | Process and intermediates for the preparation of 7-benzoylindolin-2-ones | |
EP0013188A3 (en) | Parainfluenza virus vaccine and its preparation | |
IL62870A0 (en) | Modulators of the immune system and methods for the preparation thereof | |
ATA409380A (de) | Vorrichtung zum speichern und umsetzen von formlingstraegerlagen | |
ZA807459B (en) | Infectious bronchitis vaccines for poultry and process for the preparation of such vaccines | |
ZA795895B (en) | Ravidomycin and process of preparation |